The frequency of bone fractures among patients with chronic kidney disease not on dialysis: two-year follow-up

1. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009 (113):S1-130.Search in Google Scholar

2. EKNOYAN G., LAMEIRE N., BARSOUM R., ECKARDT KU., LEVIN A., LEVIN N., et al. The burden of kidney disease: improving global outcomes. Kidney Int.2004; 66 (4):1310-4.10.1111/j.1523-1755.2004.00894.x15458424Open DOISearch in Google Scholar

3. ANPALAHAN M., VENKATESAN S., ANPALAHAN A. Fragility fractures in chronic kidney disease: assesment and pharmacologic management. Advances in Nephrology. vol. 2014, Article ID 727135, 7 pages, 2014. doi:10.1155/2014/727135.10.1155/2014/727135Search in Google Scholar

4. HAMDY NA., KANIS JA., BENETON MN., BROWN CB., JUTTMANN JR., JORDANS JG., et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995; 310:358-63.10.1136/bmj.310.6976.35825487617677827Search in Google Scholar

5. OZMEN B. Use of bisphosphonates in chronic kidney disease. World J Nephrol Urol. 2012; 1 (1):1-7.10.4021/wjnu5eSearch in Google Scholar

6. Fracture Risk Assessment Tool. Centre for Metabolic Bone Diseases, University of Sheffield, UK. Available from: https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9.Search in Google Scholar

7. NICKOLAS TL., LEONARD MB., SHANE E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int. 2008; 74 (6):721-31.10.1038/ki.2008.264413904218563052Open DOISearch in Google Scholar

8. ALEM AM, SHERRARD DJ, GILLEN DL, WEISS NS, BERESFORD SA, HECKBERT SR, et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000; 58:396-9.10.1046/j.1523-1755.2000.00178.x10886587Open DOISearch in Google Scholar

9. COCO M., RUSH H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000; 36:1115–21.10.1053/ajkd.2000.1981211096034Search in Google Scholar

10. NICKOLAS TL., MCMAHON DJ., SHANE E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006; 17:3223-32.10.1681/ASN.200511119417005938Search in Google Scholar

11. ROBBINS J., ARAGAKI AK., KOOPERBERG C., WATTS N., WACTAWSKI-WENDE J., JACKSON RD., et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA2007; 298: 2389-98.10.1001/jama.298.20.238918042916Search in Google Scholar

12. DEYL V., FARRAH TE., TRAYNOR JP., SPALDING EM., ROBERTSON SE., GEDDES CC. Symptomatic fracture risk in the renal replacement therapy population. Nephrol. Dial. Transplant. (2016). doi: 10.1093/ndt/gfw222.10.1093/ndt/gfw22227257273Open DOISearch in Google Scholar

13. AYUS JC., FUENTES NA., NEGRE AL., MORITY ML., GIUNTA DH., KALANTAR-ZADEH K., et al. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol. Dial. Transplant. (2016). doi: 10.1093/ndt/gfw029.10.1093/ndt/gfw02927190372Open DOISearch in Google Scholar

14. RIX M., ANDREASSEN H., ESKILDSEN P., LANGDAHL B., OLGAARD K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999; 56:1084-1093.10.1046/j.1523-1755.1999.00617.x10469378Search in Google Scholar

15. RUSSO CR., TACCETTI G., CANEVA P., MANNARINO A., MARANGHI P., RICCA M. Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int. 1998; 8:443-8.10.1007/s0019800500899850352Search in Google Scholar

16. JAMAL SA., GILBERT J., GORDON C., BAUER DC. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res. 2006; 21:543-8.10.1359/jbmr.06010516598374Search in Google Scholar

17. MAGNUSSON P., SHARP CA., MAGNUSSON M., RISTELI J., DAVIE MW., LARSSON L. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 2001; 60:257-65.10.1046/j.1523-1755.2001.00794.x11422759Open DOISearch in Google Scholar

18. MARUYAMA Y., TANIGUCHI M., KAZAMA JJ., YOKOYAMA K., HOSOYA T., YOKOO T., et al. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant. 2014; 29:1532-8.10.1093/ndt/gfu05524642419Search in Google Scholar

19. SARDIWAL S., MAGNUSSON P., GOLDSMITH DJ., LAMB EJ. Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis 2013; 62:810-22.10.1053/j.ajkd.2013.02.36623623575Open DOISearch in Google Scholar

20. PARK JC., KOVESDY CP., DUONG U., STREJA E., RAMBOD M., NISSENSON AR., et al. Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int 2010; 14:182-92.10.1111/j.1542-4758.2009.00430.x550975320345388Open DOISearch in Google Scholar

21. LERTDUMRONGLUK P., LAU WL., PARK J., RHEE CM., KOVESDY CP., KALANTAR-ZADEH K. Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant 2013; 28:2535-45.10.1093/ndt/gft290378483923904397Search in Google Scholar

22. KOVESDY CP., URECHE V., LU JL., KALANTAR-ZADEH K. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant 2010; 25:3003-11.10.1093/ndt/gfq144294883420299338Search in Google Scholar

23. JADOUL M., ALBERT JM., AKIBA T., AKIZAWA T., ARAB L., BRAGG-GRESHAM JL., et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2006; 70:1358-66.10.1038/sj.ki.5001754Search in Google Scholar

24. QI Q., MONIER-FAUGERE MC., GENG Z., MALLUCHE HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis. 1995; 26(4):622-31.10.1016/0272-6386(95)90599-5Open DOISearch in Google Scholar

25. TORRES A., LORENZO V., HERNANDEZ D., RODRIGUEZ JC., CONCEPCION MT., RODRIGUEZ AP., et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney International.1995; 47 (5):1434-42.10.1038/ki.1995.201Search in Google Scholar

26. IIMORI S., MORI Y., AKITA W., KUYAMA T., TAKADA S., ASAI T., et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients – a single-center cohort study. Nephrol Dial Transplant 2012; 27:345-51.10.1093/ndt/gfr317Search in Google Scholar

27. LIN JH. Bisphosponates: a review of their pharmacokinetic properties. Bone. 1996; 18(2):75-85.10.1016/8756-3282(95)00445-9Open DOISearch in Google Scholar

28. CONTR P., GUARNERI V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimen. The Oncologist.2004; 9 (Suppl 4): 28-37.10.1634/theoncologist.9-90004-2815459427Open DOISearch in Google Scholar

29. SHERRARD DJ., HERCZ G., PEI Y., MALONEY NA., GREENWOOD C., MANUEL A., et al. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int. 1993; 43(2):436-42.10.1038/ki.1993.648441240Open DOISearch in Google Scholar

30. LEVIN A., BAKRIS GL., MOLITCH M., SMULDERS M., TIAN J., WILIAMS LA., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71:31-8.10.1038/sj.ki.500200917091124Search in Google Scholar